What Is LSD? Definition, Full Name & Meaning Explained

Most people have heard of LSD. Far fewer actually know what it is — what the letters stand for, where it comes from, why it’s so potent, and what it means in scientific terms versus how it gets talked about on the street. This article fixes that.

Whether you’re a student writing a paper, a parent trying to understand what your teenager might encounter, a researcher looking for a factually grounded starting point, or simply someone who prefers knowing the actual facts about a drug rather than the myths — this is a complete, plain-language breakdown of what LSD is, what LSD stands for, and what the LSD name actually tells you about the compound itself.

Full Name: Lysergic Acid Diethylamide German Origin: LysergSäureDiethylamid (LSD) Other Name: Lysergide (INN); Acid (street) Chemical Formula: C₂₀H₂₅N₃O  |  Molecular Weight: 323.4 g/mol CAS Number: 50-37-3 Drug Class: Serotonergic psychedelic / Classical hallucinogen Legal Status: Schedule I (US), Class A (UK), Schedule III (Canada) First Synthesized: November 16, 1938 — Albert Hofmann, Sandoz Laboratories

LSD stands for lysergic acid diethylamide. That’s the complete, official chemical name of the compound. But the abbreviation itself has a small wrinkle worth knowing: the letters don’t map neatly onto the English name the way you might expect.

Breaking Down the LSD Name: What Each Part Means

Understanding the full name of LSD isn’t just trivia — it tells you something meaningful about what the compound is and where it comes from chemically.

• Lysergic — derived from lysergic acid, a naturally occurring compound found in ergot alkaloids. Lysergic acid itself comes from ergot, a fungus (Claviceps purpurea) that infects rye and other grain crops. The word “lysergic” is constructed from “lys-” (from Greek lysis, meaning dissolution or loosening) and “ergot.”
• Acid — in the chemical sense, this refers to the carboxylic acid group present in lysergic acid’s molecular structure. It’s not “acid” in the colloquial or corrosive sense. The street name “acid” is a shorthand derived from this part of the full chemical name.
• Diethylamide — refers to the amide group formed when lysergic acid reacts with diethylamine during synthesis. “Di” means two, “ethyl” refers to the two-carbon ethyl groups, and “amide” is the chemical bond type. This modification — converting lysergic acid into its diethylamide — is what produces LSD’s dramatic psychoactive potency.

In short: lysergic acid + diethylamide = LSD. The chemical name is a literal description of how the molecule is constructed. Take ergot-derived lysergic acid, attach a diethylamide group, and you have lysergic acid diethylamide — one of the most potent psychoactive compounds ever discovered.

What Is LSD? A Precise, Science-Based Definition

LSD is a semisynthetic psychedelic compound. Let’s unpack each word of that description, because precision matters here.

Semisynthetic

LSD is not a fully synthetic compound invented from scratch in a lab, and it’s not a fully natural substance either. It sits in between. The starting material — lysergic acid — is obtained from ergot alkaloids, which are natural products of the ergot fungus. From there, chemists add the diethylamide group through laboratory synthesis. This process requires significant technical expertise and controlled precursor chemicals, which is one reason pure LSD is relatively uncommon in illicit markets compared to simpler synthetic drugs.

This semisynthetic origin puts LSD in a similar category to other ergoline-derived compounds, including some legitimate medications. Ergotamine — used to treat migraines — comes from the same fungal source. So does bromocriptine, used in Parkinson’s disease treatment. LSD’s relatives aren’t all counterculture drugs; some are standard pharmacology.

Psychedelic

The word psychedelic — coined by British psychiatrist Humphry Osmond in a 1957 letter to Aldous Huxley — comes from the Greek psyche (mind) and delos (manifest or visible). A psychedelic, in the pharmacological sense, is a substance that reliably alters perception, cognition, and mood in a dose-dependent way primarily through agonism at the serotonin 5-HT2A receptor.

LSD belongs to the class of “classical” or “serotonergic” psychedelics — a group that also includes psilocybin (from Psilocybe mushrooms), mescaline (from the peyote cactus), and DMT (dimethyltryptamine, found in ayahuasca). These compounds are grouped together not by their chemistry but by their shared mechanism: they all act primarily at the 5-HT2A receptor and produce qualitatively similar perceptual alterations. LSD is notably different from dissociative drugs like ketamine or PCP, which act on NMDA receptors, and from deliriants like scopolamine.

The Official LSD Definition from Major Authorities

It helps to see how major medical, legal, and linguistic authorities actually define LSD:

• Merriam-Webster: “a semisynthetic illicit organic compound C20H25N3O derived from ergot that induces extreme sensory distortions, altered perceptions of reality, and intense emotional states”
• DEA (U.S. Drug Enforcement Administration): “a potent hallucinogen that has a high potential for abuse and currently has no accepted medical use in treatment in the United States” — classified as Schedule I
• EUDA (European Union Drugs Agency, formerly EMCDDA): “a semi-synthetic hallucinogen, and one of the most potent drugs known” — with International Non-proprietary Name (INN) of lysergide
• MedlinePlus (National Institutes of Health): “an illegal street drug that comes as a white powder or clear colorless liquid” that “acts on your brain (central nervous system) and changes your mood, behavior, and the way you relate to the world around you”
• Alcohol and Drug Foundation (ADF): “a psychedelic drug which means it can affect all senses, altering a person’s thinking, sense of time and emotions”

Notice the consistency across sources: psychedelic, semisynthetic, ergot-derived, Schedule I. The disagreements tend to emerge not around what LSD is but around how it should be treated — legally, medically, and culturally.

What Is LSD Short For — And Why Does the Abbreviation Stick?

Pharmacology and medicine use formal names for compounds: you’ll see lysergide (the INN), LSD-25 (reflecting it was the 25th compound tested in the lysergic acid series at Sandoz), and the IUPAC name — 9,10-didehydro-N,N-diethyl-6-methylergoline-8β-carboxamide — in technical publications. But in virtually every other context, the abbreviation LSD dominates.

The reason is straightforward: the full chemical name is unwieldy. “Lysergic acid diethylamide” is five syllables longer than LSD. Chemists, clinicians, regulators, journalists, and casual users all gravitated to the abbreviation almost immediately after the compound was introduced. By the time Sandoz was marketing it as Delysid in the 1950s, LSD was already the dominant shorthand in clinical research literature. When it entered popular culture in the 1960s, LSD was simply too entrenched to be displaced by anything else.

Why LSD-25 Specifically?

The “25” in LSD-25 reflects the compound’s position in a systematic research sequence. Albert Hofmann was synthesizing and testing a series of lysergic acid derivatives at Sandoz, exploring their potential pharmaceutical applications — particularly looking at effects on circulation and respiration. LSD was the 25th compound in that series. LSD-1 through LSD-24 were other derivatives that showed less pharmacological interest. LSD-25 was initially set aside in 1938 when animal studies didn’t show the expected results. Five years later, Hofmann returned to synthesize a new batch — and the rest is pharmacological history.

LSD-25 wasn’t named for any special reason — it was simply the 25th compound in Sandoz’s lysergic acid research series. Hofmann resynthesized it in 1943 and accidentally discovered its psychedelic effects.

LSD Meaning Across Different Contexts

One complication when searching for “LSD meaning” online is that the abbreviation doesn’t belong exclusively to the drug. Depending on context, LSD may also refer to:

• LSD (currency) — in British pre-decimal notation, £sd or LSD stood for librae, solidi, denarii — pounds, shillings, and pence. This is a completely unrelated Latin abbreviation that predates the drug by centuries.
• LSD (military) — Landing Ship Dock, a class of amphibious assault ship used by the U.S. Navy and other naval forces.
• LSD (automotive) — Limited Slip Differential, a type of vehicle drivetrain component. Completely unrelated to the drug.
• LSD Dream Emulator — a 1998 PlayStation game by Asmik Ace Entertainment, inspired by the designer’s dream journal. Not directly related to the drug, though the name is intentional wordplay.

In drug-related contexts — which is by far the most common usage today — LSD always refers to lysergic acid diethylamide. The other meanings have largely retreated from common usage; most people under 60 encounter LSD first as the drug.

LSD vs Acid: The Naming Overlap

“Acid” is the most widely used street name for LSD and is essentially a shorthand version of “lysergic acid.” The two names refer to the same compound. However, the practical implication of the street name is important: substances sold as “acid” on illicit markets are not always LSD. Testing services and harm reduction organizations have documented widespread adulteration with NBOMe compounds, 2C-family drugs, and DOx compounds — some of which have very different risk profiles and narrower safety margins than genuine LSD.

The LSD name, in this sense, carries specificity that the street name “acid” does not. LSD refers to one exact compound — C₂₀H₂₅N₃O — while “acid” could mean anything from authentic LSD to a dangerous substitute. This distinction isn’t semantic hairsplitting. It’s harm reduction.

The LSD Full Form in Scientific Literature

In peer-reviewed pharmacology and neuroscience literature, LSD appears consistently as both an abbreviation and in its full form. It’s useful to know what that literature actually looks like, because the way LSD is described in scientific contexts can differ meaningfully from how it appears in popular media.

Key Scientific Entities Associated with LSD’s Definition

Reading about LSD across the top research sources, you’ll encounter a consistent cluster of terms, people, and organizations. Knowing these entities helps you evaluate source credibility and understand the scientific frame around the compound:

• Albert Hofmann (1906–2008) — Swiss chemist, Sandoz Laboratories. Synthesizer of LSD-25 on November 16, 1938. Author of LSD: My Problem Child (1979), the foundational first-person account of LSD’s discovery and early research.
• Sandoz Laboratories — Basel, Switzerland pharmaceutical company. Marketed LSD as Delysid from the mid-1950s through the 1960s for psychiatric research. Withdrew Delysid from circulation in 1965 under regulatory pressure.
• 5-HT2A receptor (serotonin 2A receptor) — the primary target through which LSD produces its psychedelic effects. LSD acts as a partial agonist at this receptor, which explains its perceptual and cognitive effects.
• Ergot / Claviceps purpurea — the fungus from which ergot alkaloids, including lysergic acid (LSD’s precursor), are derived. Ergot contamination of rye caused historical outbreaks of ergotism — a condition also known as “Saint Anthony’s Fire.”
• Ergoline family — the chemical class to which LSD belongs. Includes ergotamine (migraine medication), bromocriptine (Parkinson’s treatment), and LSA (lysergic acid amide, found in morning glory seeds).
• Bicycle Day — April 19, 1943 — the date Hofmann intentionally self-administered LSD and experienced the first documented LSD trip on his bicycle ride home.
• Delysid — Sandoz’s commercial brand name for LSD from the 1950s–60s. Distributed to clinicians and researchers for experimental psychiatric use, including studies on psychosis models, alcoholism, and anxiety treatment.
• Humphry Osmond — British psychiatrist who coined the term “psychedelic” in 1957. Conducted early LSD research and corresponded extensively with Aldous Huxley.
• MK-Ultra — the CIA’s covert mind-control research program (1953–1973), which involved administering LSD to subjects without consent, including military personnel and civilians. Documented through FOIA disclosures; Sidney Gottlieb directed the program.
• NIDA (National Institute on Drug Abuse) — the primary U.S. federal body for drug research, which maintains factsheets on LSD as part of its public health mandate.
• EUDA / EMCDDA — the European Union Drugs Agency, which maintains the EU’s authoritative drug profile for lysergide, including its INN, IUPAC name, CAS number, and pharmacological data.
• Hallucinogen Persisting Perception Disorder (HPPD) — a documented neurological condition involving persistent visual disturbances following hallucinogen use, including LSD. Recognized in the DSM-5.
• Owsley Stanley — the most prolific illicit LSD manufacturer in the United States during the 1960s, known for producing large quantities of high-purity LSD at a standard dose of approximately 270 micrograms per unit.

LSD Meaning in Pop Culture vs. Scientific Reality

There’s a consistent gap between how LSD is described in popular culture and how it appears in scientific literature. Understanding that gap is part of understanding what LSD actually is.

Pop Culture Frame

Popular culture — from 1960s counterculture to contemporary media — tends to frame LSD through a few well-worn narratives: the mystical experience, the bad trip, the creative breakthrough, the counterculture rebellion. Names like Timothy Leary (“Turn on, tune in, drop out”), Ken Kesey and the Merry Pranksters, the Grateful Dead, and the Beatles’ psychedelic era all come attached to the cultural meaning of LSD. These aren’t irrelevant — they’re real history — but they tell you about the social context of LSD use, not about what the compound is.

Scientific Frame

Scientific literature describes LSD through its molecular properties, receptor pharmacology, metabolic pathway, and clinical effects. In this frame, LSD is most accurately understood as a potent, highly specific partial agonist at the 5-HT2A serotonin receptor, with a molecular weight of 323.4 g/mol, a plasma half-life of approximately 2–5 hours, and active effects at oral doses as low as 20 micrograms.

LSD’s extreme potency relative to other psychoactive drugs is one of its most scientifically notable features. Microgram-level activity is unusual; most drugs are active in milligram quantities. Psilocybin, for comparison, is effective at doses roughly 200 times higher than LSD. Mescaline requires approximately 5,000 times the dose. This potency doesn’t make LSD more dangerous in terms of toxicity — its LD50 in animals is extremely high and lethal human overdoses from pharmacological toxicity alone are extraordinarily rare — but it does mean that dosing precision matters enormously.

Harm Reduction Frame

From a harm reduction perspective, understanding exactly what LSD is — its full name, its synthesis requirements, its specific molecular identity — matters because it helps people evaluate whether what they’re holding is actually LSD. The Ehrlich reagent test (p-dimethylaminobenzaldehyde) reacts with indole alkaloids, turning purple or blue in the presence of LSD. A negative Ehrlich test strongly suggests the substance is not LSD, which is critical information given that NBOMe compounds — some of which are dangerous at doses that would be subthreshold for LSD — have been widely sold as acid.

Conclusion: Actionable Takeaways

Understanding what LSD is, what it stands for, and what its name actually means gives you a factual foundation that most online content fails to provide. Here are the key points to carry forward:

• LSD stands for lysergic acid diethylamide — abbreviated from the German LysergSäureDiethylamid because it was first synthesized in Switzerland.
• The full name is descriptive — “lysergic” refers to ergot-derived lysergic acid, “acid” to the carboxylic acid group in its structure, and “diethylamide” to the synthetic modification that creates the compound’s psychoactivity.
• LSD-25 was the 25th compound — in Albert Hofmann’s lysergic acid research series at Sandoz Laboratories, first synthesized November 16, 1938, with psychedelic effects discovered accidentally on April 16, 1943.
• LSD and acid are the same thing — “acid” is a street abbreviation of “lysergic acid.” However, substances sold as acid on illicit markets are not always genuine LSD.
• LSD is a serotonergic psychedelic — classified as Schedule I in the United States, Class A in the UK, Schedule III in Canada. Internationally, it falls under the 1971 UN Convention on Psychotropic Substances.
• The Ehrlich reagent is the practical verification tool — if you need to identify whether a substance is LSD, a positive Ehrlich test (purple/blue color) confirms the presence of an indole alkaloid consistent with LSD.
• Regulatory context is shifting — the FDA’s 2024 breakthrough therapy designation for MindMed’s MM-120 (an LSD formulation targeting generalized anxiety disorder) marks a meaningful change in how LSD’s medical potential is officially evaluated in the United States.

If you’re looking to go deeper on specific aspects of LSD — how it works pharmacologically, what it looks like in its various street forms, its legal status across jurisdictions, or the current state of clinical research — each of those topics has dedicated coverage in this guide.

Keywords Covered in This Article

• For reference, this article directly addresses the following search terms:
• what is lsd
• lsd meaning
• lsd definition
• lsd full name
• lsd full form
• what does lsd stand for
• lsd stands for
• lsd name
• what is lsd short for

About the Author

Dr. Sarah Kellerman, PhD (Pharmacology), MPH Senior Research Pharmacologist | Drug Policy Consultant | Public Health Educator  Dr. Kellerman holds a PhD in Pharmacology from Johns Hopkins University and a Master of Public Health from Columbia University’s Mailman School of Public Health. She has spent 15 years researching psychoactive compounds, with a focus on serotonergic drugs and their interaction with human neurochemistry. Her academic work has appeared in journals including Neuropsychopharmacology, Drug and Alcohol Dependence, and PLOS ONE. She has served as a technical advisor to harm reduction organizations in the United States and Europe and has contributed to drug education curricula adopted by three U.S. state health departments. Dr. Kellerman has no financial relationships with pharmaceutical companies developing psychedelic therapeutics. Her writing prioritizes evidence-based accuracy, avoiding both sensationalism and minimization — she believes people make better decisions when given real information.

Sources & References

1. Hofmann, A. (1979). LSD: My Problem Child. McGraw-Hill, New York.

2. Nichols, D.E. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264–355. doi:10.1124/pr.115.011478